NEW DELHI: The government may need ₹Rs 80 billion over the next year for the distribution of the covid-19 vaccine to all people in India, Serum Institute of India Executive Director Adar Poonawalla said on Saturday, calling it a “worrying challenge.” “Will the government of India have Rs 80 billion …
Read More »‘Significant Move’ in Russia’s Request for Phase 3 Trial, Sputnik V Manufacturing in India | India News
NEW DELHI: India is considering Russia’s request to conduct a phase 3 clinical trial and the manufacture of its Covid-19 Sputnik V vaccine by Indian companies, officials said Tuesday, noting there has been “significant movement” on both fronts. and specific results are expected. soon. Dr VK Paul, Member (Health) Niti …
Read More »